Prescribing Biologic Immune-Modifying Therapies for Patients with a History of Cancer: A Cross-Specialty Review

Stephanie Bowe, Seamus O’Reilly, Michelle Murphy, Anne O’Mahony, Sinead Harney, Akbar Zulquernain, John Bourke · 2026

Read Prescribing Biologic Immune-Modifying Therapies for Patients with a History of Cancer: A Cross-Specialty Review by Stephanie Bowe, Seamus O’Reilly, Michelle Murphy, Anne O’Mahony, Sinead Harney, Akbar Zulquernain, John Bourke (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13511177.txt.

Description

Stephanie Bowe and six co-authors review whether biologic immune drugs can be given safely to people who have had cancer, in 2026 work. These drugs transformed care for psoriasis, arthritis, and asthma, yet they dampen immunity, which raises fears of feeding a past or current cancer. Patients with cancer were shut out of the key trials, leaving doctors with thin direct proof.

Large health databases and real-world reports suggest the drugs can be used with care in some patients with a past cancer after joint discussion across specialties. Evidence for people with active cancer stays very limited, and most studies still exclude those with any cancer history. The authors call for longer follow-up and for registries that include such patients from the start, using new data tools to watch outcomes across wider groups.

Catalog record

CREATORStephanie Bowe, Seamus O’Reilly, Michelle Murphy, Anne O’Mahony, Sinead Harney, Akbar Zulquernain, John Bourke
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE116130
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13511177

Browse the full library · About the Tower of Babel